Clinical Trial Update: Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of Simeprevir, Daclatasvir and Sofosbuvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy, safety, tolerability, and pharmacokinetics of a triple-drug regimen (simeprevir, daclatasvir, sofosbuvir) in treatment-na…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Daklinza (Daclatasvir)
• Olysio (Simeprevir)
• Sovaldi (Sofosbuvir)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Hepatitis C Virus | Phase 2 | Status: COMPLETED | Results posted: 2017-03-01